| Multi-clonal evolution of multi-drug-resistant/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over … A Bainomugisa, E Lavu, S Hiashiri, S Majumdar, A Honjepari, R Moke, ... Microbial genomics 4 (2), e000147, 2018 | 46 | 2018 |
| Cross-border movement of highly drug-resistant Mycobacterium tuberculosis from Papua New Guinea to Australia through Torres Strait Protected Zone, 2010–2015 A Bainomugisa, S Pandey, E Donnan, G Simpson, E Lavu, S Hiasihri, ... Emerging infectious diseases 25 (3), 406, 2019 | 25 | 2019 |
| Multi-clonal evolution of MDR/XDR M. tuberculosis in a high prevalence setting in Papua New Guinea over three decades A Bainomugisa, E Lavu, S Hiashiri, S Majumdar, A Honjepari, R Moke, ... bioRxiv, 172601, 2017 | 6 | 2017 |
| Impact of GxAlert on the management of rifampicin-resistant tuberculosis patients, Port Moresby, Papua New Guinea JK Banamu, E Lavu, K Johnson, R Moke, SS Majumdar, KC Takarinda, ... Public Health Action 9 (1), S19-S24, 2019 | 5 | 2019 |
| Characterization of pncA mutations in multi-drug and pyrazinamide resistant Mycobacterium tuberculosis isolates cultured from Queensland migrants and Papua New Guinea residents S Pandey, E Lavu, J Congdon, R Moke, A Bainomugisa, C Coulter Tuberculosis 111, 109-113, 2018 | 5 | 2018 |
| TB epidemiology and responses in Papua New Guinea R Moke Burnet Institute, 2015 | 1 | 2015 |
